AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
Go back to AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions| (NASDAQ: ABCL) | Delayed: 12.63 -0.1 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.73 | 52 Week High | $ | |||
| Open | $12.73 | 52 Week Low | $ | |||
| Day High | $12.96 | P/E | N/A | |||
| Day Low | $12.37 | EPS | $ | |||
| Volume | 5,437,651 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 508.34 -8 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $516.34 | 52 Week High | $134.71 | |||
| Open | $516.34 | 52 Week Low | $73.31 | |||
| Day High | $518.10 | P/E | N/A | |||
| Day Low | $505.01 | EPS | $-1.98 | |||
| Volume | 2,434,829 | |||||
